3% And above5 Oct 2023 18:05
Just for the record and as updated - albeit late
Significant Shareholders
As at 31st August 2023 significant shareholders that hold more than 3% of the share capital of SkinBioTherapeutics plc are detailed below:
Number Ordinary Shares %
OptiBiotix Health Plc 27,190,639 15.70%
Seneca Partners Limited 16,475,376 9.52%
Tyndall Investment Management 13,165,553 7.60%
The University of Manchester 8,000,000 4.62%
Director Shareholders
Number Ordinary Shares %
Martin Hunt* 560,417 0.32%
Stuart John Ashman 276,804 0.16%
Manprit Randhawa 153,165 0.09%
Dr Cathy Prescott 181,112 0.10%
Danielle Bekker 43,750 0.03%
*Martin Hunt’s shareholding is held through Invictus Management Limited, a company controlled by Mr Hunt. Of the 560,417 shares held by Invictus Management Limited 11,112 are held in trust for Louise Hunt and 11,111 are held in trust for Oliver Hunt.
Significant Shareholders
as at 31st January 2023 significant shareholders that hold more than 3% of the share capital of SkinBioTherapeutics plc are detailed below:
OptiBiotix Health Plc 32,402,206 18.71%
Seneca Partners Limited 16,475,376 9.52%
Tyndall Investment Management 13,165,553 7.60%
The University of Manchester 8,000,000 4.62%
Director Shareholders
Martin Hunt* 560,417 0.32%
Stuart John Ashman 281,250 0.16%
Manprit Randhawa 156,250 0.09%
Dr Cathy Prescott 181,112 0.10%
Danielle Bekker 43,750 0.03%
*Martin Hunt’s shareholding is held through Invictus Management Limited, a company controlled by Mr Hunt. Of the 560,417 shares held by Invictus Management Limited 11,112 are held in trust for Louise Hunt and 11,111 are held in trust for Oliver Hunt.
mol